These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9140718)

  • 21. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
    Cario H; Wegener M; Debatin KM; Kohne E
    Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
    Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
    Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GENETIC FACTORS INFLUENCING HEMOGLOBIN F LEVEL IN β-THALASSEMIA/HB E DISEASE.
    Ruangrai W; Jindadamrongwech S
    Southeast Asian J Trop Med Public Health; 2016 Jan; 47(1):84-91. PubMed ID: 27086429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic response to hydroxyurea therapy in children with beta-thalassemia major.
    Mtvarelidze Z; Kvezereli-Kopadze A; Kvezereli-Kopadze M; Mestiashvili I
    Georgian Med News; 2008 Mar; (156):91-4. PubMed ID: 18403819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child.
    Pirastru M; Manca L; Trova S; Mereu P
    Biomed Res Int; 2017; 2017():1261972. PubMed ID: 28553644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic measurement of hemoglobin F in blood obtained from patients with hemoglobin E/E and beta-thalassemia/hemoglobin/E.
    Tatsumi N; Tsuda I; Funahara Y; Bunyaratvej A; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():91-4. PubMed ID: 1284356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
    Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
    Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous Hemoglobin Lepore: A Rare Condition Seen in a Bangladeshi Family.
    Aziz MA; Khan WA; Das SA; Banu B
    Mymensingh Med J; 2021 Oct; 30(4):1172-1176. PubMed ID: 34605493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin Lepore Hollandia in India.
    Nadkarni A; Italia K; Sawant P; Ghosh K; Colah R
    Int J Lab Hematol; 2012 Apr; 34(2):148-53. PubMed ID: 21895987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of hemoglobin Lepore (deltabeta hybrid hemoglobin) with various hemoglobinopathies: A molecular and hematological characteristics and differential diagnosis.
    Chaibunruang A; Srivorakun H; Fucharoen S; Fucharoen G; Sae-ung N; Sanchaisuriya K
    Blood Cells Mol Dis; 2010 Mar; 44(3):140-5. PubMed ID: 20022270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.
    Loovers HM; Tamminga N; Mulder AB; Tamminga RY
    Hemoglobin; 2016 Sep; 40(5):341-344. PubMed ID: 27686852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia.
    Bradai M; Abad MT; Pissard S; Lamraoui F; Skopinski L; de Montalembert M
    Blood; 2003 Aug; 102(4):1529-30. PubMed ID: 12702505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis.
    Algiraigri AH; Kassam A
    Int J Hematol; 2017 Dec; 106(6):748-756. PubMed ID: 28786080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
    Ren Q; Zhou YL; Wang L; Chen YS; Ma YN; Li PP; Yin XL
    Ann Hematol; 2018 Oct; 97(10):1933-1939. PubMed ID: 29931453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients.
    Chondrou V; Kolovos P; Sgourou A; Kourakli A; Pavlidaki A; Kastrinou V; John A; Symeonidis A; Ali BR; Papachatzopoulou A; Katsila T; Patrinos GP
    Hum Genomics; 2017 Oct; 11(1):24. PubMed ID: 29061162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.